Northern Trust Corp 4 D Molecular Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 430,683 shares of FDMT stock, worth $3.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

430,683

Previous 367,479 17.2%

Holding current value

$3.27 Million

Previous $7.71 Million 39.65%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.81 - $27.22 $683,235 - $1.72 Million	63,204 Added 17.2%	430,683 $4.66 Million
Q2 2024 Aug 14, 2024	SELL	$20.93 - $30.01 $140,293 - $201,157	-6,703 Reduced 1.79%	367,479 $7.71 Million
Q1 2024 May 14, 2024	BUY	$17.03 - $35.87 $150,528 - $317,054	8,839 Added 2.42%	374,182 $11.9 Million
Q4 2023 Feb 13, 2024	BUY	$9.76 - $21.25 $15,791 - $34,382	1,618 Added 0.44%	365,343 $7.4 Million
Q3 2023 Nov 13, 2023	BUY	$12.64 - $19.76 $396,365 - $619,634	31,358 Added 9.43%	363,725 $4.63 Million
Q2 2023 Aug 11, 2023	BUY	$15.16 - $23.26 $878,340 - $1.35 Million	57,938 Added 21.11%	332,367 $6.01 Million
Q1 2023 May 15, 2023	SELL	$15.45 - $23.19 $6,056 - $9,090	-392 Reduced 0.14%	274,429 $4.72 Million
Q4 2022 Feb 13, 2023	SELL	$6.85 - $25.46 $12,734 - $47,330	-1,859 Reduced 0.67%	274,821 $6.1 Million
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.48 $16,349 - $26,966	2,349 Added 0.86%	276,680 $2.22 Million
Q2 2022 Aug 12, 2022	BUY	$5.68 - $15.99 $85,489 - $240,665	15,051 Added 5.8%	274,331 $1.92 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $22.64 $64,589 - $111,117	4,908 Added 1.93%	259,280 $3.92 Million
Q4 2021 Feb 08, 2022	BUY	$19.56 - $32.94 $1.26 Million - $2.13 Million	64,547 Added 34.0%	254,372 $5.58 Million
Q3 2021 Nov 15, 2021	BUY	$22.73 - $36.04 $2.08 Million - $3.29 Million	91,297 Added 92.66%	189,825 $5.12 Million
Q2 2021 Aug 13, 2021	BUY	$22.2 - $42.29 $252,747 - $481,471	11,385 Added 13.06%	98,528 $2.37 Million
Q1 2021 May 12, 2021	BUY	$35.94 - $52.67 $3.13 Million - $4.59 Million	87,143 New	87,143 $3.78 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $246M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp 4 D Molecular Therapeutics, Inc. Transaction History